Pharma news
Pharma
SNIPR Biome has five patents reinstated after court rules they cannot be subject to interference | Rockefeller University had challenged patents on pre-AIA, first-to-invent basis. 20 July 2023
Americas
Polpharma’s injunction bid fails as motion is dismissed with prejudice | Court upholds Swiss Arbitration process. 20 July 2023
Pharma
Delaware court permits counterclaims from Vizgen and Nanostring in separate suits | Firms say patents-in-suit were covered by ‘open and non-exclusive licenses’. 13 July 2023
Pharma
Commission says dealmakers ‘knowingly and intentionally’ breached standstill obligation | Grail receives the first-ever fine for a target company under EU merger rules. 13 July 2023
Pharma
With competition, employee mobility and chatbots all on the rise, protecting IP as trade secrets has never been more important for life sciences firms, says Anthony Fitzpatrick of Duane Morris. 5 July 2023
Pharma
Verdict confirms legality of 2014 patent settlement, dismissing allegations of anti competitive practices. 4 July 2023
Pharma
Board did not violate procedure regarding ‘preliminary guidance’ say Federal Circuit judges | Medytox’s substitute claims found to be ‘unpatentable’. 29 June 2023
Pharma
Revocation and infringement actions involving a cholesterol treatment, prosthetic valves, and methods for analyte detection are among the first to land at the court within its first month, explain Joanne Welch and Darren Smyth of EIP. 29 June 2023
Pharma
UPC Administrative Committee 'voted unanimously' to approve Milan says Italian politician | Court will hear patent cases related to “pharmaceutical, phytosanitary, agri-food and fashion” | Chemistry and metallurgy moving to Munich, excluding SEPs. 27 June 2023
Americas
Commission argues that a New York federal court erred in its finding that deals between an AbbVie unit and generic manufacturers were justified | US Supreme Court previously ruled that “unjustified” reverse payments can violate the antitrust laws. 22 June 2023